Related Experiment Video
Updated: Sep 16, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
A comparative analysis of three pharmacovigilance system assessment tools
Muhammad Akhtar Abbas Khan1,2, Jude Nwokike3, Asim Rauf2
1Department of Public Health, Health Services Academy, Islamabad, Pakistan.
Assessing national pharmacovigilance systems requires careful tool selection. Evaluating the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), WHO Pharmacovigilance Indicators, and WHO Global Benchmarking Tool (GBT) reveals their unique strengths and limitations for comprehensive analysis.
Area of Science:
- Pharmacovigilance
- Drug Safety Assessment
- Regulatory Science
Background:
- National pharmacovigilance systems are crucial for monitoring drug safety.
- Key assessment tools include the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), World Health Organization (WHO) Pharmacovigilance Indicators, and the WHO Global Benchmarking Tool (GBT).
- These tools evaluate national regulatory authority functionality within pharmacovigilance.
Purpose of the Study:
- To identify, analyze, and compare the core characteristics of major pharmacovigilance assessment tools.
- To understand the scope, application, and limitations of IPAT, WHO Pharmacovigilance Indicators, and GBT.
- To inform best practices for evaluating national pharmacovigilance systems.
Main Methods:
- Structured document analysis of the three identified pharmacovigilance assessment tools.
- Systematic review, categorization, and synthesis of tool content.
- Comparative evaluation of tool design, focus areas, and assessment criteria.
Main Results:
- Available tools cover diverse pharmacovigilance dimensions: infrastructure, processes, and outcomes.
- Exclusive reliance on a single tool provides a limited perspective on national pharmacovigilance frameworks.
- Heterogeneity exists among assessment tools, impacting their comprehensive application.
Conclusions:
- A context-specific adaptation of pharmacovigilance assessment tools is essential.
- Strategic selection or integration of multiple tools ensures a comprehensive evaluation.
- Tailored approaches are recommended for accurate assessment of national pharmacovigilance systems.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact